35 / 46
AR gain is associated with an adverse
outcome with long follow-up (Median
FU 37 m)
PSA-PFS
Radiographic-PFS
Overall Survival
HR 3.84 (95%CI: 1.77- 8.31); P= <0.001
HR: 13.60 (95%CI: 5.82-31.79); P<0.0001
HR:6.36 (95%CI: 3.04-13.31); P<0.0001